Literature DB >> 7007748

Antithrombotic therapy: role of platelet-inhibitor drugs. I. Current concepts of thrombogenesis: role of platelets. (first of three parts).

V Fuster, J H Chesebro.   

Abstract

Definite evidence has confirmed that platelets play a major role in thrombus formation and embolization, especially in the arterial system. In addition, increasing evidence has now shown that platelet deposition and thrombus formation can contribute to the growth and progression of atherosclerotic plaques. For these reasons, considerable attention has been focused recently on the question of whether drugs that inhibit certain platelet functions can prevent or modify the course of arterial thromboembolic disease and atherosclerotic disease in humans. In this first part, we review the current understanding of the role of platelets in thrombus formation, especially in the arterial system. This section comprises (1) the phases of arterial thrombus formation and its ultrastructural and biochemical basis, (2) the clinicopathologic presentation and fate of the arterial thrombus, and (3) the role of laboratory tests in its detection.

Entities:  

Mesh:

Year:  1981        PMID: 7007748

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  7 in total

Review 1.  Myocardial infarction in patients with normal coronary arteries: proposed pathogenesis and predisposing risk factors.

Authors:  S P Pinney; L E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

Review 2.  Dietary fish oils containing eicosapentaenoic acid and the prevention of atherosclerosis and thrombosis.

Authors:  B J Holub
Journal:  CMAJ       Date:  1988-09-01       Impact factor: 8.262

3.  Therapeutic lidocaine concentrations have no effect on blood platelet function and plasma catecholamine levels.

Authors:  R F Berntsen; T Simonsen; G Sager; H Olsen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.

Authors:  I B Johnstone
Journal:  Can J Comp Med       Date:  1983-04

Review 5.  Bioengineering aspects of heart valve replacement.

Authors:  F J Schoen; J L Titus; G M Lawrie
Journal:  Ann Biomed Eng       Date:  1982       Impact factor: 3.934

6.  Effects of propranolol in vitro and in vivo on platelet function and thromboxane formation in normal volunteers.

Authors:  W Siess; R Lorenz; P Roth; P C Weber
Journal:  Agents Actions       Date:  1983-02

7.  BF066, a novel dual target antiplatelet agent without significant bleeding.

Authors:  ChangE Pan; Xunbin Wei; Jianqin Ye; Guangda Liu; Si Zhang; Yan Zhang; Hongguang Du; Zhongren Ding
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.